Le Lézard
Classified in: Health, Business
Subject: SVY

Yes, there's still a nursing shortage; Qualivis offers ideas for managing it


COLUMBIA, S.C., Sept. 19, 2018 /PRNewswire/ -- Despite record levels of college enrollment and growing interest in nursing careers among Millennials, the shortage of qualified nurses isn't expected to ease anytime soon. That was the message from Joe Dunmire, executive director of Qualivis, at a recent conference of healthcare hiring managers and recruiters.

Healthcare staffing firm unveils new plan, new brand (PRNewsfoto/Qualivis)

"Statistics can be misleading. Currently there are nearly 3 million jobs for registered nurses, and there are more than 2.9 million licensed RNs, which doesn't seem like a significant shortage," he said. "But 21 percent of licensed RNs are not engaged in patient care, which makes the actual deficit nearly 700,000."

Nationally, expectations are that there will be more than a million RN vacancies by 2024, he said, more than twice the deficit of the last major nursing shortage.

Qualivis, a workforce solutions company, helps roughly 400 hospitals nationwide fill their vacancies, so Dunmire sees the challenges of finding and keeping good nurses on a daily basis. "Today, nursing is second only to the hospitality industry in turnover," he said. "Roughly one in five nurses leaves the job after one year. And the average cost of losing a nurse is nearly $50,000."

Dunmire outlined several solutions, including:

"There are a few basic facts that we can all agree on," Dunmire said. "One, nursing continues to be one of the most in-demand professions today. Two, nursing continues to be the most trusted profession in America. And, three, there is a wealth of research showing a direct correlation between quality nurses and positive patient outcomes. For all of these reasons, we need to ensure that there is always an adequate supply of quality nurses."

 

SOURCE Qualivis


These press releases may also interest you

at 20:50
Pharma (1167.HK), a clinical-stage oncology company drugging the undruggable targets, today announced its 2023 annual results. The revenue was RMB63.5 million, the R&D investment was RMB372 million, the cash and cash equivalent at the end of 2023 was...

at 20:35
InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company announced that the first patient in China has been dosed in the Phase 1b clinical study of the combination of InnoCare's novel SHP2 (Src Homology 2 domain containing...

at 19:30
Willow Biosciences Inc. ("Willow" or the "Company") , a leading biotechnology...

at 18:56
Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:...

at 18:30
Striking Teamsters at pharmaceutical giant Cencora (formerly known as AmerisourceBergen) rallied today outside the company's Sacramento distribution center. The 124 warehouse workers are members of Teamsters Local 150 and have been on strike since...

at 18:00
Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis, and inflammation, announced a research collaboration with Dr. Jessica M. Konen's Lab at Emory University School of Medicine....



News published on and distributed by: